2117 related articles for article (PubMed ID: 32514174)
1. A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
Wilk AJ; Rustagi A; Zhao NQ; Roque J; Martínez-Colón GJ; McKechnie JL; Ivison GT; Ranganath T; Vergara R; Hollis T; Simpson LJ; Grant P; Subramanian A; Rogers AJ; Blish CA
Nat Med; 2020 Jul; 26(7):1070-1076. PubMed ID: 32514174
[TBL] [Abstract][Full Text] [Related]
2. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.
Zhang F; Gan R; Zhen Z; Hu X; Li X; Zhou F; Liu Y; Chen C; Xie S; Zhang B; Wu X; Huang Z
Signal Transduct Target Ther; 2020 Aug; 5(1):156. PubMed ID: 32796814
[TBL] [Abstract][Full Text] [Related]
3. A single-cell atlas of the peripheral immune response to severe COVID-19.
Wilk AJ; Rustagi A; Zhao NQ; Roque J; Martinez-Colon GJ; McKechnie JL; Ivison GT; Ranganath T; Vergara R; Hollis T; Simpson LJ; Grant P; Subramanian A; Rogers AJ; Blish CA
medRxiv; 2020 Apr; ():. PubMed ID: 32511639
[TBL] [Abstract][Full Text] [Related]
4. Single-cell landscape of immunological responses in patients with COVID-19.
Zhang JY; Wang XM; Xing X; Xu Z; Zhang C; Song JW; Fan X; Xia P; Fu JL; Wang SY; Xu RN; Dai XP; Shi L; Huang L; Jiang TJ; Shi M; Zhang Y; Zumla A; Maeurer M; Bai F; Wang FS
Nat Immunol; 2020 Sep; 21(9):1107-1118. PubMed ID: 32788748
[TBL] [Abstract][Full Text] [Related]
5. Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients.
Angioni R; Sánchez-Rodríguez R; Munari F; Bertoldi N; Arcidiacono D; Cavinato S; Marturano D; Zaramella A; Realdon S; Cattelan A; Viola A; Molon B
Cell Death Dis; 2020 Nov; 11(11):957. PubMed ID: 33159040
[TBL] [Abstract][Full Text] [Related]
6. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
7. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.
Weiskopf D; Schmitz KS; Raadsen MP; Grifoni A; Okba NMA; Endeman H; van den Akker JPC; Molenkamp R; Koopmans MPG; van Gorp ECM; Haagmans BL; de Swart RL; Sette A; de Vries RD
Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32591408
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.
Lee JS; Park S; Jeong HW; Ahn JY; Choi SJ; Lee H; Choi B; Nam SK; Sa M; Kwon JS; Jeong SJ; Lee HK; Park SH; Park SH; Choi JY; Kim SH; Jung I; Shin EC
Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32651212
[TBL] [Abstract][Full Text] [Related]
9. A human circulating immune cell landscape in aging and COVID-19.
Zheng Y; Liu X; Le W; Xie L; Li H; Wen W; Wang S; Ma S; Huang Z; Ye J; Shi W; Ye Y; Liu Z; Song M; Zhang W; Han JJ; Belmonte JCI; Xiao C; Qu J; Wang H; Liu GH; Su W
Protein Cell; 2020 Oct; 11(10):740-770. PubMed ID: 32780218
[TBL] [Abstract][Full Text] [Related]
10. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.
Arunachalam PS; Wimmers F; Mok CKP; Perera RAPM; Scott M; Hagan T; Sigal N; Feng Y; Bristow L; Tak-Yin Tsang O; Wagh D; Coller J; Pellegrini KL; Kazmin D; Alaaeddine G; Leung WS; Chan JMC; Chik TSH; Choi CYC; Huerta C; Paine McCullough M; Lv H; Anderson E; Edupuganti S; Upadhyay AA; Bosinger SE; Maecker HT; Khatri P; Rouphael N; Peiris M; Pulendran B
Science; 2020 Sep; 369(6508):1210-1220. PubMed ID: 32788292
[TBL] [Abstract][Full Text] [Related]
11. Immune dysfunction following COVID-19, especially in severe patients.
Song CY; Xu J; He JQ; Lu YQ
Sci Rep; 2020 Sep; 10(1):15838. PubMed ID: 32985562
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell immunotypes related to COVID-19 disease severity.
Maucourant C; Filipovic I; Ponzetta A; Aleman S; Cornillet M; Hertwig L; Strunz B; Lentini A; Reinius B; Brownlie D; Cuapio A; Ask EH; Hull RM; Haroun-Izquierdo A; Schaffer M; Klingström J; Folkesson E; Buggert M; Sandberg JK; Eriksson LI; Rooyackers O; Ljunggren HG; Malmberg KJ; Michaëlsson J; Marquardt N; Hammer Q; Strålin K; Björkström NK;
Sci Immunol; 2020 Aug; 5(50):. PubMed ID: 32826343
[TBL] [Abstract][Full Text] [Related]
13. Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.
Park JH; Lee HK
Front Immunol; 2020; 11():2145. PubMed ID: 32983174
[TBL] [Abstract][Full Text] [Related]
14.
Bao R; Hernandez K; Huang L; Luke JJ
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32675312
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
[TBL] [Abstract][Full Text] [Related]
18. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
Schulte-Schrepping J; Reusch N; Paclik D; Baßler K; Schlickeiser S; Zhang B; Krämer B; Krammer T; Brumhard S; Bonaguro L; De Domenico E; Wendisch D; Grasshoff M; Kapellos TS; Beckstette M; Pecht T; Saglam A; Dietrich O; Mei HE; Schulz AR; Conrad C; Kunkel D; Vafadarnejad E; Xu CJ; Horne A; Herbert M; Drews A; Thibeault C; Pfeiffer M; Hippenstiel S; Hocke A; Müller-Redetzky H; Heim KM; Machleidt F; Uhrig A; Bosquillon de Jarcy L; Jürgens L; Stegemann M; Glösenkamp CR; Volk HD; Goffinet C; Landthaler M; Wyler E; Georg P; Schneider M; Dang-Heine C; Neuwinger N; Kappert K; Tauber R; Corman V; Raabe J; Kaiser KM; Vinh MT; Rieke G; Meisel C; Ulas T; Becker M; Geffers R; Witzenrath M; Drosten C; Suttorp N; von Kalle C; Kurth F; Händler K; Schultze JL; Aschenbrenner AC; Li Y; Nattermann J; Sawitzki B; Saliba AE; Sander LE;
Cell; 2020 Sep; 182(6):1419-1440.e23. PubMed ID: 32810438
[TBL] [Abstract][Full Text] [Related]
19. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
[TBL] [Abstract][Full Text] [Related]
20. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.
De Biasi S; Lo Tartaro D; Meschiari M; Gibellini L; Bellinazzi C; Borella R; Fidanza L; Mattioli M; Paolini A; Gozzi L; Jaacoub D; Faltoni M; Volpi S; Milić J; Sita M; Sarti M; Pucillo C; Girardis M; Guaraldi G; Mussini C; Cossarizza A
Eur J Immunol; 2020 Sep; 50(9):1283-1294. PubMed ID: 32910469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
